McKenna Mark C.
SEC CIK 1749623 · EDGAR
Most active insiders at FRNM, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Elliott Aaron Matthew | CEO, Dir | — | — |
| 2 | Perceptive Capital Solutions Holdings | Former 10% Owner | — | — |
| 3 | McKenna Mark C. | Former Dir | — | — |
| 4 | ALTMAN MICHAEL SETH | Former Dir, Ofc, 10% Ownr | — | — |
| 5 | Stone Adam Leo | Former Dir, Ofc, 10% Ownr | — | — |
| 6 | SONG KENNETH | Former Dir | — | — |
| 7 | Waksal Harlan | Former Dir | — | — |
| 8 | RA CAPITAL MANAGEMENT, L.P. | Dir, 10% | — | — |
| 9 | PERCEPTIVE ADVISORS LLC | 10% | — | — |
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-07-22 19:21 | 2026-07-20 | FRNM | Freenome, Inc. | McKenna Mark C. | Former Dir | C - Cnv Deriv | — | +30.0K | 30.0K | New | — |
| D | 2026-01-09 | 2026-01-07 | NAMS | NewAmsterdam Pharma Co N.V. | McKenna Mark C. | Dir | A - Grant | — | +3,400 | 10.4K | +49% | — |
| D | 2025-08-11 | 2025-08-11 | BBOT | BridgeBio Oncology Therapeutics, Inc. | McKenna Mark C. | Former Dir | M - OptEx | — | +30.0K | 30.0K | New | — |
| D | 2025-01-08 | 2025-01-07 | NAMS | NewAmsterdam Pharma Co N.V. | McKenna Mark C. | Dir | A - Grant | — | +6,960 | 6,960 | New | — |
Purchase Sale Sale after option exercise All abbreviations